{"id":24835,"date":"2024-01-02T10:33:00","date_gmt":"2024-01-02T10:33:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=24835"},"modified":"2025-07-16T16:23:14","modified_gmt":"2025-07-16T23:23:14","slug":"ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/","title":{"rendered":"Ziextenzo: Prevenci\u00f3n y tratamiento de la neutropenia febril en pacientes con c\u00e1ncer"},"content":{"rendered":"<p>Ziextenzo (nombre gen\u00e9rico: pegfilgrastim-bmez), es un medicamento aprobado por la FDA que se usa para tratar o prevenir la fiebre.&nbsp;<a href=\"https:\/\/www.cancer.net\/coping-with-cancer\/physical-emotional-and-social-effects-cancer\/managing-physical-side-effects\/neutropenia\">neutropenia<\/a>Se utiliza en pacientes con c\u00e1ncer no mieloide que reciben quimioterapia mielosupresora. La neutropenia es una afecci\u00f3n en la que los pacientes presentan un nivel anormalmente bajo de neutr\u00f3filos, un tipo de gl\u00f3bulo blanco necesario para combatir infecciones. En el caso de la neutropenia febril, el nivel bajo de neutr\u00f3filos se acompa\u00f1a de fiebre.<\/p>\n\n\n\n<div  id=\"call-to-action-b4717cc7ec4a38a25936207703ac30b0\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de quimioterapia\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAsistencia financiera para quimioterapia\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>La neutropenia inducida por quimioterapia se produce porque esta no puede diferenciar entre c\u00e9lulas sanas y malignas. Ataca y destruye las c\u00e9lulas cancerosas, pero tambi\u00e9n puede da\u00f1ar las c\u00e9lulas sanas, incluidos los neutr\u00f3filos. Esta disminuci\u00f3n de neutr\u00f3filos causa neutropenia, lo que hace a los pacientes extremadamente susceptibles a infecciones graves y posiblemente mortales.<\/p>\n\n\n\n<p>El Ziextenzo est\u00e1 indicado para disminuir la incidencia de infecciones mediante el aumento transitorio de los niveles de neutr\u00f3filos en pacientes con c\u00e1ncer. Se administra por v\u00eda subcut\u00e1nea (bajo la piel) despu\u00e9s de cada ciclo de quimioterapia.<\/p>\n\n\n\n<p>Actualmente, Ziextenzo s\u00f3lo est\u00e1 disponible como soluci\u00f3n en jeringas precargadas (0,6 ml de soluci\u00f3n de Ziextenzo en cada jeringa para una sola dosis) y requiere prescripci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Mechanism_of_Action\" >Mecanismo de acci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Ziextenzo_Uses\" >Usos del Ziextenzo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Ziextenzo_vs_Neulasta\" >Ziextenzo frente a Neulasta<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Dosage_and_Administration\" >Dosis y administraci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Best_Time_To_Take_Ziextenzo\" >El mejor momento para tomar Ziextenzo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Overdose\" >Sobredosis<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Side_Effects\" >Efectos secundarios<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Common_side_effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Adverse_side_effects\" >Efectos secundarios adversos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Interaction_With_Other_Drugs\" >Interacci\u00f3n con otros medicamentos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Contraindications\" >Contraindicaciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Precautions_When_Taking_Ziextenzo\" >Precauciones al tomar Ziextenzo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#Ziextenzo_Cost\" >Costo del Ziextenzo<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span>Mecanismo de acci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ziextenzo contiene el ingrediente activo,&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/pegfilgrastim-neulasta\/\">pegfilgrastim<\/a>, que es similar a los factores estimulantes de colonias de granulocitos humanos (G-CSF). Los G-CSF son un tipo de&nbsp;<a href=\"https:\/\/www.news-medical.net\/health\/What-is-a-Glycoprotein.aspx\">glicoprote\u00edna<\/a>&nbsp;que se produce naturalmente en la m\u00e9dula \u00f3sea y estimula la producci\u00f3n y liberaci\u00f3n de neutr\u00f3filos desde la m\u00e9dula \u00f3sea al torrente sangu\u00edneo en condiciones normales.&nbsp;<\/p>\n\n\n\n<p>La quimioterapia tiene un impacto significativo en la producci\u00f3n de neutr\u00f3filos. El principio activo de Ziextenzo, pegfilgrastim, se une a receptores de superficie espec\u00edficos en las c\u00e9lulas de la m\u00e9dula \u00f3sea, estimulando as\u00ed una mayor producci\u00f3n de neutr\u00f3filos. Como resultado, las personas que se someten a estos tratamientos tienen menos probabilidades de desarrollar infecciones.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ziextenzo_Uses\"><\/span>Usos del Ziextenzo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Actualmente, Ziextenzo est\u00e1 aprobado por la FDA para el tratamiento de pacientes con c\u00e1ncer maligno no mieloide que presentan neutropenia febril causada por quimioterapia mielosupresora.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ziextenzo_vs_Neulasta\"><\/span>Ziextenzo frente a Neulasta<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ziextenzo es el tercero&nbsp;<a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/biosimilar-drug\">biosimilar<\/a>&nbsp;de&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/pegfilgrastim-neulasta\/\">Neulasta<\/a>&nbsp;(un medicamento aprobado por la FDA y disponible en el mercado). El Neulasta es un medicamento biol\u00f3gico complejo y costoso de producir. En cambio, el Ziextenzo es un biosimilar de menor costo y muy similar al Neulasta.<\/p>\n\n\n\n<p><strong>Muy similares<\/strong>&nbsp;significa que el medicamento ha sido sometido a rigurosas pruebas de la FDA y comparte los mismos atributos que Neulasta en t\u00e9rminos de estructura, m\u00e9todo de acci\u00f3n, pureza y potencia.&nbsp;<\/p>\n\n\n\n<p>El Ziextenzo funciona de la misma manera, ofrece los mismos beneficios y presenta los mismos efectos secundarios que el Neulasta. En otras palabras, no existe una diferencia cl\u00ednicamente significativa entre estos dos f\u00e1rmacos, salvo el costo, lo que hace que el Ziextenzo sea m\u00e1s asequible y accesible que el Neulasta.&nbsp;<\/p>\n\n\n\n<p>Adem\u00e1s, varios estudios han comparado las similitudes entre Ziextenzo y Neulasta y han informado que Ziextenzo muestra los mismos resultados que Neulasta.&nbsp;<\/p>\n\n\n\n<p>Por ejemplo, un estudio cl\u00ednico que administr\u00f3 Ziextenzo a 624 pacientes con c\u00e1ncer de mama, antes o despu\u00e9s de la quimioterapia, demostr\u00f3 ser tan eficaz como Neulasta. La reducci\u00f3n promedio en la duraci\u00f3n de la neutropenia fue de un d\u00eda.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_and_Administration\"><\/span>Dosis y administraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La dosis var\u00eda entre adultos y ni\u00f1os. El medicamento se presenta en una \u00fanica inyecci\u00f3n subcut\u00e1nea. Una jeringa precargada monodosis contiene 6 mg de pegfilgrastim en 0,6 ml de soluci\u00f3n y solo puede administrarse por v\u00eda subcut\u00e1nea (bajo la piel) en el muslo, los brazos o el abdomen.<\/p>\n\n\n\n<p>Los pacientes pedi\u00e1tricos (con un peso inferior a 45 kg o 99 libras) requieren menos de 0,6 ml (6 mg). Dado que la jeringa precargada no tiene marcas de inscripci\u00f3n, se recomienda seguir cuidadosamente las instrucciones del m\u00e9dico al administrar Ziextenzo a ni\u00f1os.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Best_Time_To_Take_Ziextenzo\"><\/span><strong>El mejor momento para tomar Ziextenzo<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los medicamentos de quimioterapia pueden detener el mecanismo de acci\u00f3n de Ziextenzo; por lo tanto, se recomienda tomarlo 14 d\u00edas antes de su ciclo de quimioterapia o al menos 24 horas despu\u00e9s de un ciclo de quimioterapia.&nbsp;<\/p>\n\n\n\n<p>Ziextenzo no debe tomarse inmediatamente antes o despu\u00e9s de un ciclo de quimioterapia.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Overdose\"><\/span><strong>Sobredosis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La sobredosis de Ziextenzo puede provocar&nbsp;<a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/17704-high-white-blood-cell-count\">leucocitosis<\/a>&nbsp;y dolor \u00f3seo. Se ha informado que un paciente con sobredosis experiment\u00f3 edema,&nbsp;<a href=\"https:\/\/my.clevelandclinic.org\/health\/symptoms\/16942-dyspnea\">disnea<\/a>, y&nbsp;<a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/17373-pleural-effusion-causes-signs--treatment\">derrame pleural<\/a>.&nbsp;<\/p>\n\n\n\n<p>Consulte a su proveedor de atenci\u00f3n m\u00e9dica o enfermera si le han administrado demasiado Ziextenzo.<\/p>\n\n\n\n<div  id=\"call-to-action-5eecdeb7b2753e93c8a8d02aadb1c792\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsulte con un especialista en quimioterapia\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el tratamiento de quimioterapia\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Efectos secundarios<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img decoding=\"async\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/ziextenzo-side-effect.jpg\" alt=\"Woman with muscle pain as a result of taking Ziextenzo\" class=\"wp-image-23736\"\/><\/figure>\n<\/div>\n\n\n<p>El Ziextenzo, como todos los medicamentos, tiene efectos secundarios. Algunos son leves (temporales) y suelen desaparecer con el tratamiento, mientras que otros son graves y requieren atenci\u00f3n m\u00e9dica inmediata.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_side_effects\"><\/span><strong>Efectos secundarios comunes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Algunos de los efectos secundarios comunes que los pacientes pueden experimentar despu\u00e9s de tomar el medicamento incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor muscular, espec\u00edficamente en brazos y piernas.<\/li>\n\n\n\n<li>Dolor \u00f3seo. Aproximadamente el 31% de los pacientes en ensayos cl\u00ednicos experimentaron dolor \u00f3seo con el uso de Ziextenzo. Si presenta dolor \u00f3seo, informe a su profesional de la salud, ya que podr\u00eda recomendarle medicamentos para controlar el dolor.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Adverse_side_effects\"><\/span><strong>Efectos secundarios adversos<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Si bien la probabilidad de efectos secundarios graves es baja, se han reportado casos cl\u00ednicos de efectos secundarios graves que pueden experimentar las personas despu\u00e9s de tomar Ziextenzo. Entre los efectos secundarios graves se incluyen:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>S\u00edndrome de dificultad respiratoria aguda (SDRA),&nbsp;<\/strong>Un problema pulmonar importante que pueden sufrir los pacientes con c\u00e1ncer que usan pegfilgrastim. Si presenta dificultad para respirar, fiebre, tos, congesti\u00f3n pulmonar o respiraci\u00f3n acelerada, contacte con su profesional de la salud de inmediato.<\/li>\n\n\n\n<li><strong>Ruptura espl\u00e9nica,&nbsp;<\/strong>Una afecci\u00f3n potencialmente mortal en la que el bazo se agranda y posiblemente se rompe despu\u00e9s de tomar Ziextenzo. Consulte con su profesional de la salud para un examen cl\u00ednico si siente dolor en la parte superior izquierda del abdomen (est\u00f3mago) o en el hombro izquierdo.&nbsp;<\/li>\n\n\n\n<li><strong>Reacciones al\u00e9rgicas graves,<\/strong>&nbsp;incluida la anafilaxia. Las personas al\u00e9rgicas a cualquiera de los ingredientes de Ziextenzo, incluido el pegfilgrastim, tienen mayor probabilidad de experimentar reacciones al\u00e9rgicas al principio de la exposici\u00f3n. Algunos de los signos al\u00e9rgicos de&nbsp;<a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/anaphylaxis\/symptoms-causes\/syc-20351468\">anafilaxia<\/a>&nbsp;Incluyen sarpullido en todo el cuerpo, hinchaz\u00f3n alrededor de los ojos y la boca, sibilancias, dificultad para respirar, ritmo card\u00edaco acelerado, sudoraci\u00f3n y fiebre. Suspenda el uso de Ziextenzo si presenta alguno de estos s\u00edntomas y llame a su profesional de la salud de inmediato.<\/li>\n\n\n\n<li><strong>Aumento de gl\u00f3bulos blancos (leucocitosis),&nbsp;<\/strong>Esto se ha observado en menos del 1% de los pacientes que recibieron Ziextenzo. Su profesional de la salud controlar\u00e1 sus hemogramas durante el tratamiento para detectar cualquier anomal\u00eda.<\/li>\n\n\n\n<li><strong>Disminuci\u00f3n del recuento de plaquetas (trombocitopenia),<\/strong>&nbsp;Esto puede ocurrir en pacientes que reciben quimioterapia y Ziextenzo. Los niveles bajos de plaquetas, en general, reducen la capacidad de coagulaci\u00f3n de la sangre, lo que provoca hemorragias internas, como hematomas, o externas, como hemorragias nasales. Su profesional de la salud controlar\u00e1 su recuento de plaquetas peri\u00f3dicamente.<\/li>\n\n\n\n<li><strong>S\u00edndrome de fuga capilar (CLS),&nbsp;<\/strong>Se ha reportado un s\u00edndrome de SLC tras la administraci\u00f3n de Ziextenzo. En este s\u00edndrome, el Ziextenzo causa una fuga masiva de l\u00edquidos de los vasos sangu\u00edneos a la circulaci\u00f3n y, si no se trata con urgencia, puede provocar insuficiencia multiorg\u00e1nica. Los s\u00edntomas reportados de SLC incluyen dificultad para respirar, hinchaz\u00f3n repentina alrededor del abdomen, n\u00e1useas, cansancio, sensaci\u00f3n de plenitud abdominal, mareos y disminuci\u00f3n de la micci\u00f3n.&nbsp;<\/li>\n\n\n\n<li><strong>Lesi\u00f3n renal (glomerulonefritis),&nbsp;<\/strong>Otro efecto secundario adverso que puede presentarse tras la administraci\u00f3n de Ziextenzo es: consulte a su profesional de la salud si presenta hinchaz\u00f3n de la cara o los tobillos, sangre en la orina, orina oscura o disminuci\u00f3n de la micci\u00f3n. Normalmente, los s\u00edntomas de glomerulonefritis disminuyen tras la reducci\u00f3n de Ziextenzo. Sin embargo, si los s\u00edntomas persisten despu\u00e9s de la reducci\u00f3n, su profesional de la salud podr\u00eda suspender el medicamento.<\/li>\n\n\n\n<li><strong>S\u00edndrome mielodispl\u00e1sico (SMD)<\/strong>&nbsp;<strong>y leucemia mieloide aguda (LMA),&nbsp;<\/strong>Esto puede ocurrir si los pacientes toman Ziextenzo en combinaci\u00f3n con quimioterapia o radioterapia. El SMD es una afecci\u00f3n sangu\u00ednea precancerosa, mientras que la leucemia mieloide aguda (LMA) es un trastorno sangu\u00edneo agudo. Los pacientes con c\u00e1ncer de mama o de pulm\u00f3n tienen mayor probabilidad de desarrollar LMA. Algunos s\u00edntomas comunes de estos dos trastornos son fiebre, cansancio y facilidad para sangrar o presentar hematomas. Se recomienda consultar a su m\u00e9dico si experimenta alguno de estos s\u00edntomas.<\/li>\n\n\n\n<li><strong>Inflamaci\u00f3n de la aorta (aortitis),&nbsp;<\/strong>Un trastorno poco com\u00fan, pero potencialmente mortal. En este trastorno, el gran vaso sangu\u00edneo que transporta sangre desde el coraz\u00f3n al resto del cuerpo se inflama y da\u00f1a. Los s\u00edntomas pueden incluir fiebre, dolor abdominal, cansancio y dolor de espalda.<\/li>\n\n\n\n<li><strong>Crisis de c\u00e9lulas falciformes<\/strong>, que puede ocurrir con el uso de Ziextenzo. Los pacientes con anemia falciforme preexistente que presenten una crisis falciforme corren el riesgo de morir si no reciben tratamiento urgente. Consulte a su profesional de la salud si experimenta s\u00edntomas como dificultad para respirar o dolor.&nbsp;<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-a4829c459ab2fc8a6ea21f9efd88349d\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista \t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Interaction_With_Other_Drugs\"><\/span>Interacci\u00f3n con otros medicamentos<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Existe la posibilidad de que Ziextenzo interact\u00fae con otros medicamentos que est\u00e9 tomando junto con Ziextenzo. Informe a su profesional de la salud sobre todos los medicamentos de venta libre (OTC), herbales y con receta que est\u00e9 tomando.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Contraindications\"><\/span>Contraindicaciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ziextenzo est\u00e1 contraindicado en pacientes al\u00e9rgicos al pegfilgrastim o a productos con filgrastim.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precautions_When_Taking_Ziextenzo\"><\/span>Precauciones al tomar Ziextenzo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Informe a su proveedor de atenci\u00f3n m\u00e9dica antes de usar Ziextenzo si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Est\u00e1 embarazada o tiene intenci\u00f3n de tener un hijo.&nbsp;<\/li>\n\n\n\n<li>Est\u00e1 amamantando o planea amamantar<\/li>\n\n\n\n<li>Tiene anemia falciforme<\/li>\n\n\n\n<li>Tiene alergia al l\u00e1tex.<\/li>\n\n\n\n<li>Tiene problemas de ri\u00f1\u00f3n, coraz\u00f3n, h\u00edgado u otros \u00f3rganos.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ziextenzo_Cost\"><\/span>Costo del Ziextenzo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Una jeringa monodosis de Ziextenzo (6 mg\/0,6 ml) cuesta aproximadamente $4.143,09, aunque el precio puede variar seg\u00fan la farmacia y la cobertura del seguro. El fabricante ofrece un &quot;Programa de Copago Comercial&quot; para ayudar a los consumidores con seguros comerciales a pagar los copagos. No dude en contactarnos.&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a>&nbsp;Si necesita apoyo financiero.<\/p>","protected":false},"excerpt":{"rendered":"<p>Ziextenzo (nombre gen\u00e9rico: pegfilgrastim-bmez) es un medicamento aprobado por la FDA que se utiliza para tratar o prevenir la neutropenia febril. Se utiliza en pacientes con c\u00e1ncer no mieloide que reciben quimioterapia mielosupresora. La neutropenia es una afecci\u00f3n en la que los pacientes presentan un nivel anormalmente bajo de neutr\u00f3filos, un tipo de gl\u00f3bulo blanco necesario para combatir infecciones.<\/p>","protected":false},"author":27,"featured_media":24836,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[],"class_list":["post-24835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn how Ziextenzo is used to treat febrile neutropenia. Topics include mechanism of action, dosage, side effects, precautions, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn how Ziextenzo is used to treat febrile neutropenia. Topics include mechanism of action, dosage, side effects, precautions, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-02T10:33:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T23:23:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients\",\"datePublished\":\"2024-01-02T10:33:00+00:00\",\"dateModified\":\"2025-07-16T23:23:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/\"},\"wordCount\":1495,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cancer-patient.jpg\",\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/\",\"name\":\"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cancer-patient.jpg\",\"datePublished\":\"2024-01-02T10:33:00+00:00\",\"dateModified\":\"2025-07-16T23:23:14+00:00\",\"description\":\"Learn how Ziextenzo is used to treat febrile neutropenia. Topics include mechanism of action, dosage, side effects, precautions, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cancer-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cancer-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Young adult female cancer patient wearing headscarf and bathrobe sitting in the kitchen looking out window.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/cancer\\\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ziextenzo: Prevenci\u00f3n y tratamiento de la neutropenia febril en pacientes con c\u00e1ncer - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Aprenda c\u00f3mo se usa el Ziextenzo para tratar la neutropenia febril. Los temas incluyen el mecanismo de acci\u00f3n, la dosis, los efectos secundarios, las precauciones y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/","og_locale":"es_MX","og_type":"article","og_title":"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients - AmeriPharma\u00ae Specialty Care","og_description":"Learn how Ziextenzo is used to treat febrile neutropenia. Topics include mechanism of action, dosage, side effects, precautions, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-01-02T10:33:00+00:00","article_modified_time":"2025-07-16T23:23:14+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients","datePublished":"2024-01-02T10:33:00+00:00","dateModified":"2025-07-16T23:23:14+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/"},"wordCount":1495,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg","articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/","url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/","name":"Ziextenzo: Prevenci\u00f3n y tratamiento de la neutropenia febril en pacientes con c\u00e1ncer - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg","datePublished":"2024-01-02T10:33:00+00:00","dateModified":"2025-07-16T23:23:14+00:00","description":"Aprenda c\u00f3mo se usa el Ziextenzo para tratar la neutropenia febril. Los temas incluyen el mecanismo de acci\u00f3n, la dosis, los efectos secundarios, las precauciones y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg","width":1280,"height":853,"caption":"Young adult female cancer patient wearing headscarf and bathrobe sitting in the kitchen looking out window."},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/ziextenzo-preventing-and-treating-febrile-neutropenia-in-cancer-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Ziextenzo: Preventing and Treating Febrile Neutropenia in Cancer Patients"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"Ziextenzo (generic name: pegfilgrastim-bmez), is an FDA-approved medication used to treat or prevent febrile neutropenia. It is used in cancer patients with non-myeloid malignancies who are receiving myelosuppressive chemotherapy medications. Neutropenia is a condition in which patients have an abnormally lower level of neutrophils \u2014 a type of white blood cell that is needed to&hellip;","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/02\/cancer-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Ziextenzo (generic name: pegfilgrastim-bmez), is an FDA-approved medication used to treat or prevent febrile neutropenia. It is used in cancer patients with non-myeloid malignancies who are receiving myelosuppressive chemotherapy medications. Neutropenia is a condition in which patients have an abnormally lower level of neutrophils \u2014 a type of white blood cell that is needed to&hellip;","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=24835"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24835\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/24836"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=24835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=24835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=24835"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}